Alternative macrophage polarisation associated with resistance to anti-PD1 blockade is possibly supported by the splicing of FKBP51 immunophilin in melanoma patients.

Troiani, Teresa; Giunta, Emilio Francesco; Tufano, Martina; Vigorito, Vincenza; Arrigo, Paolo D'; Argenziano, Giuseppe; Ciardiello, Fortunato; Romano, Maria Fiammetta; Romano, Simona

Troiani, Teresa; Giunta, Emilio Francesco; Tufano, Martina; Vigorito, Vincenza; Arrigo, Paolo D'; Argenziano, Giuseppe; Ciardiello, Fortunato; Romano, Maria Fiammetta; Romano, Simona.

Afiliación

Troiani T; Department of Precision Medicine, Oncology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
Giunta EF; Department of Precision Medicine, Oncology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
Tufano M; Department of Molecular Medicine and Medical Biotecnology, University of Naples Federico II, Naples, Italy.
Vigorito V; Department of Molecular Medicine and Medical Biotecnology, University of Naples Federico II, Naples, Italy.
Arrigo P; Department of Molecular Medicine and Medical Biotecnology, University of Naples Federico II, Naples, Italy.
Argenziano G; Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
Ciardiello F; Department of Precision Medicine, Oncology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
Romano MF; Department of Molecular Medicine and Medical Biotecnology, University of Naples Federico II, Naples, Italy. mariafiammetta.romano@unina.it.
Romano S; Department of Molecular Medicine and Medical Biotecnology, University of Naples Federico II, Naples, Italy. simona.romano@unina.it.

Br J Cancer ; 122(12): 1782-1790, 2020 06.

Article en En | MEDLINE | ID: mdl-32317723

Asunto(s)

Resistencia a Antineoplásicos/inmunología; Macrófagos/inmunología; Melanoma/inmunología; Proteínas de Unión a Tacrolimus/metabolismo; Anciano; Anticuerpos Monoclonales Humanizados/uso terapéutico; Antígeno B7-H1/antagonistas & inhibidores; Femenino; Humanos; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Inmunoterapia/métodos; Activación de Macrófagos/inmunología; Macrófagos/metabolismo; Masculino; Melanoma/tratamiento farmacológico; Melanoma/metabolismo; Persona de Mediana Edad; Nivolumab/uso terapéutico; Isoformas de Proteínas; Linfocitos T Reguladores/inmunología; Linfocitos T Reguladores/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Proteínas de Unión a Tacrolimus / Macrófagos / Melanoma Tipo de estudio: Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google